Heme oxygenase 1 (HO-1), a stress response protein, is highly induced in response to various agents causing oxidative stress including ultraviolet irradiation, sodium arsenite, hyperoxia, and glutathione depletors. 
THE PRIMARY FUNCTION of heme oxygenase (HO)
2 is to catalyze the oxidative degradation of heme to biliverdin, which is subsequently reduced to bilirubin (1) . Equimolar amounts of carbon monoxide and iron are released during the initial step of heme catalysis and the liberated iron often is sequestered into ferritin. HO exists as three isoforms-HO-1, HO-2, and most recently HO-3-all of which are generated from distinct genes (1, 2) . Although these isoforms are present in a wide variety of tissues, HO-2 and HO-3 appear to be constitutively expressed whereas HO-1 is highly inducible. In addition to its major substrate, heme, HO-1 synthesis is known to be up-regulated by a variety of non-heme inducers including heavy metals, cytokines, hormones, endotoxin, and heat shock (3) (4) (5) . In light of the observations that biliverdin and bilirubin are powerful antioxidants and heme is a pro-oxidant, it has been suggested that increased HO activity provides cytoprotection against oxidative damage. Indeed, emerging evidence suggests that HO-1 induction may mediate cellular protection against oxidant insults both in vitro (6) (7) (8) and in vivo (9, 10) .
We previously demonstrated that nitric oxide (NO) increased steady-state levels of HO-1 mRNA independent of the soluble guanylate cyclase-cGMP pathway (11) . Indeed NO is one of the most potent inducers of HO-1 gene expression identified to date.
Since NO itself is a free radical and can interact with other free radicals such as superoxide anion, we hypothesized that the addition of antioxidants might inhibit NO-induced HO-1 gene expression. Pretreatment of cells with the antioxidant N-acetyl-L-cysteine (NAC) ablated nitric oxide-induced HO-1 gene expression; however, pyrrolidine dithiocarbamate (PDTC), a strong antioxidant and iron chelator, surprisingly stimulated HO-1 gene expression commensurate to that of NO itself. In addition to their metal chelating properties, dithiocarbamates represent a class of antioxidants known to be potent inhibitors of nuclear factor-kB (NF-kB). In this respect, PDTC is thought to be one of the most effective NF-kB inhibitors because of its ability to traverse the cell membrane and its prolonged stability in solution at physiologic pH (12) . Dithiocarbamates are currently being advocated as a treatment to retard the onset of acquired immune deficiency syndrome (AIDS) in human immunodeficiency virus (HIV) infected people, and more recently have been advocated for limiting neutrophil-mediated oxidant injury (12, 13) . To date, the protective effects of dithiocarbamates have been attributed directly to either their antioxidant properties or their ability to inhibit NF-kB, but it is becoming increasingly appreciated that at least PDTC has the potential to activate endogenous antioxidant genes expression as well as modulate the redox state of cells, independent of any effects on NFkB (14) . In this paper we demonstrate that PDTC alone is a potent inducer of the stress-inducible gene HO-1 in aortic vascular smooth muscle (aVSM) cells. Furthermore, we show that the transcription factor activator protein 1 (AP-1) plays an important role in mediating PDTC-induced HO-1 gene transcription.
MATERIALS AND METHODS
Cell culture RAW 264.7 murine macrophage cells were obtained from the American Tissue Type Collection (Rockville, Md.). Primary cultures of rat aVSM cells were generously provided by Dr. Michael Crow of the National Institute of Aging/NIH (Baltimore, Md.). Cells were maintained in Dulbecco's modified Eagle's medium (Gibco BRL Laboratories; Grand Island, N.Y.) supplemented with 10% fetal bovine serum (Hyclone Laboratories; Logan, Utah) and gentamicin (50 mg/ml). Cultures were maintained at 37ЊC in a humidified atmosphere of 5% C0 2 /95% air. All experiments were performed with confluent cultures. Experiments using aVSM cells were performed between passages 10 and 20.
Chemicals
PDTC, actinomycin D (0.5 mg/ml) , and cycloheximide (5 mg/ ml) were obtained from Sigma (St. Louis, Mo.). All experiments using PDTC were performed at dose of 2 mM unless indicated otherwise.
RNA extraction and Northern blot analyses
Total RNA was isolated by the STAT-60 RNAzol method with direct lysis of cells in RNAzol lysis buffer, followed by chloroform extraction (Tel-Test 'B' Inc., Friendswood, Tex.). Northern blot analyses were performed as previously described (4). Ten micrograms of total RNA was electrophoresed in a 1% agarose gel, transferred to Gene Screen Plus nylon membrane (Dupont; Boston, Mass.) by capillary action, and cross-linked with a UV Stratalinker (Stratagene; La Jolla, Calif.). The nylon membranes were prehybridized in hybridization buffer (1% BSA, 7% sodium dodecyl sulfate (SDS), 0.5 M phosphate buffer, pH 7.0, 1.0 mM EDTA) at 65ЊC for 2 h, followed by incubation in hybridization buffer containing 32 Plabeled rat HO-1 cDNA at 65ЊC for 24 h. Nylon membranes were then washed twice in buffer A (0.5% BSA, 5% SDS, 40 mM phosphate buffer, pH 7.0, 1 mM EDTA) for 15 min at 55ЊC, followed by four washes in buffer B (1% SDS, 40 mM phosphate buffer, pH 7.0, 1.0 mM EDTA) for 15 min at 55ЊC. Ethidium bromide staining of the gel was used to confirm RNA integrity. To further control for variation in either the amount of RNA in different samples or loading errors, blots were hybridized with an oligonucleotide probe complementary to 18s rRNA after stripping of the HO-1 probe. Autoradiographic signals were quantified by densitometric scanning (Molecular Dynamics; Sunnyvale, Calif.). All densitometric values obtained for the HO-1 mRNA transcript (1.8 kb) were normalized to values for 18s rRNA obtained on the same blot. The HO-1 mRNA level in treated cells was expressed in densitometric absorbance units, normalized to control untreated samples, and expressed as fold induction compared to controls.
cDNA and oligonucleotide probes
A full-length rat HO-1 cDNA, generously provided by Dr. S. Shibahara of Tohoku University, Japan (15) , was subcloned into pBluescript vector and HindIII/EcoRI digestion was performed to isolate a 0.9 kb HO-1 cDNA subfragment. A 24 base pair oligonucleotide (5-ACGGTATCT GATCGTCTT-CGAACC-3) complementary to 18s rRNA was synthesized using a DNA synthesizer (Applied Biosystems; Foster City, Calif.). HO-1 cDNA was labeled with [a-32 P]CTP using a random primer kit (Boehringer-Mannheim; Mannheim, Germany). The 18s rRNA oligonucleotide was labeled with [a- 32 P]ATP at the 3 end with terminal deoxynucleotidyl transferase (Bethesda Research Laboratories; Gaithersburg, Md.).
Western blot analyses
For HO-1 immunoblots, cells were homogenized in lysis buffer (1% NP-40, 20 mM Tris pH 8.0, 137.5 mM NaCl, 1 mM Na 3 VO 4 , 1 mM PMSF, 10 mg/ml aprotinin). Protein concentrations of the lysates were determined by Coomassie blue dye binding assay (Bio-Rad Laboratories, Hercules, Calif.). An equal volume of 21 SDS/sample buffer (0.125 M Tris-HCl, pH 7.4, 4% SDS, and 20% glycerol) was added, and the samples were boiled for 5 min. Samples (100 mg) were subjected to electrophoresis in a 12% SDS-polyacrylamide gel (Novex; San Diego, Calif.) for 2 h at 20 mA. The proteins were then transferred electrophoretically (Bio-Rad Laboratories) onto a polyvinylidene fluoride membrane (Immobilon; Bedford, Mass.) and incubated for 2 h in TTBS buffer (Tris-buffered saline and 1% polyoxyethylene sorbitan monolaurate) containing 5% nonfat powdered milk. The membranes were then incubated for 2 h with rabbit polyclonal antibody against rat HO-1 (1:1,000 dilution). Rat HO-1 antibody was purchased from Stress Gen (Vancouver, Canada). After three washes in / 383c de17 Mp 1677 Wednesday Oct 21 12:44 PM LP-FASEB de17 TTBS for 5 min each, the membranes were incubated with goat anti-rabbit IgG antibody (Amersham; Arlington Heights, Ill.) for 2 h. The membranes were then washed three times in TTBS for 5 min each, followed by detection of signal by using an ECL detection kit (Amersham).
Cellular nuclear protein extraction
Cells were scraped in cold phosphate-buffered saline and centrifuged at 14,000 1 g at 4ЊC for 10 min. After the supernatant was discarded, the cell pellet was lysed in lysis buffer containing 10 mM HEPES pH 7.9, 1 mM EDTA, 60 mM KCl, 1 mM DTT, 0.5% NP-40, and 1 mM PMSF. The lysate was chilled in ice for 5 min then centrifuged at 1500 1 g to obtain nuclei. The nuclei were washed in lysis buffer without NP-40 and centrifuged again at 1500 1 g for 5 min. The supernatant was removed and the pellet was resuspended in nuclear resuspension buffer containing 25 mM Tris pH 7.8, 60 mM KCl, 1 mM DTT, and 1 mM PMSF. The nuclei were then frozen and thawed three times to obtain nuclear protein. The protein was kept in nuclear resuspension buffer and stored at 080ЊC.
Electrophoretic mobility shift assay
Mobility shift assays were performed as previously described (4). DNA binding activity was determined after incubation of nuclear protein extract (5 mg) with 10 fmol (20,000-50,000 cpm) of a 32 2P-labeled 22-mer oligonucleotide encompassing the AP-1 site (5CTAGTGATGAGTCAGCCGGATC 3) (Stratagene; La Jolla, Calif.) in reaction buffer containing 10 mM Hepes (pH 7.9), 1 mM DTT, 1 mM EDTA, 80 mM potassium chloride, 1 mg poly [dIdC], and 4% Ficoll. After a 20 min incubation, the reaction mixture was electrophoresed on a 6% polyacrylamide gel. The gel was transferred to DE81 ion exchange chromatography paper (Whatman; Maidstone, England) and dried down prior to exposure to autoradiographic film.
Plasmid constructs and mutations
The construction and characterization of the plasmid pMHO1CAT, the mouse extended HO-1 promoter (1.3 kb) linked to the reporter gene chloramphenicol acetyl transferase (CAT), has been described previously (16) . The construction of pMHO1CAT-33/SX2, which contains the 5 distal enhancer fragment of the HO-1 gene (SX2) linked to the minimal promoter and reporter gene CAT, has also been described (16) . The construction of pMHO11CAT, which contains a large portion of the 5 flanking region of the HO-1 gene linked to the reporter gene CAT, was done by cloning the 11.5 kb (03.5 to 015 kb) Bam HI/ Bam HI fragment of lMHO2-1 (17) into the Bam HI site upstream of the HO-1 promoter in plasmid pMHO1CAT. The construction of pMHO1CAT/RH2, the 5 flanking region of the HO-1 gene containing the second distal enhancer AB1 site linked to the reporter gene CAT, has been described previously (18) .
Plasmids (10 mg) containing the various constructs were stably cotransfected into RAW 264.7 cells with pcDNA3-Neo (1 mg), a plasmid containing neomycin selection marker, using Lipofectin reagent (Gibco BRL) as previously described (4). In brief, cells were transfected for 24 h and then incubated in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 50 mg/ml gentamicin, supplemented by increasing amounts of Geneticin (Gibco BRL) every 3 days until reaching a maximum dose of 800 mg/ml.
Site-directed mutagenesis
Oligonucleotide-directed mutagenesis to generate mutant plasmids pMHO1CATD-33/AB1M16 (one AP-1 binding site mutated), pMHO1CATD-33/AB1M31 (two AP-1 binding sites mutated), and pMHO1CATD-33/AB1M45 (three AP-1 binding sites mutated) has been described previously (18) . The construction of the wild-type plasmid pMHO1CATD-33/AB1 (containing the second distal enhancer AB1 linked to the minimal promoter of the HO-1 gene) has also been described (18) Chloramphenicol acetyltransferase assay Cellular protein extracts were prepared within 24 h after termination of PDTC treatment. Cells from 10 cm plates were washed with ice-cold phosphate-buffered saline, resuspended in 1.0 ml of 0.25 M Tris-HCl (pH 7
RESULTS

PDTC induces HO-1 gene and protein expression
Northern blot analyses were performed to examine the steady-state levels of HO-1 mRNA in primary cultures of rat aVSM cells after exposure to the antioxidant PDTC. Total RNA was isolated at 2, 4 h, 8 h, and 24 h after PDTC (2 mM) treatment and analyzed for HO-1 mRNA expression (Fig. 1A) . HO-1 mRNA levels were induced in a time-dependent manner. A low basal level of HO-1 transcript was detected by densitometer to allow determination of fold induction. Increased HO-1 mRNA levels were observed at 2 h, with peak induction at 4-8 h and reduced, but still significantly increased HO-1 mRNA levels, at 24 h of PDTC treatment. Induction of HO-1 mRNA is also dose dependent as evidenced by increases in mRNA expression by doses of PDTC ranging from 2 mM to 2 mM (Fig. 1B) . Minimal induction of HO-1 mRNA was evident at 0.002 mM PDTC, with marked increases in HO-1 mRNA present at 0.02 mM PDTC, 0.2 mM PDTC, and 2.0 mM PDTC. All subsequent experiments involving PDTC were performed using a concentration of 2 mM. Cells did not exhibit cytotoxicity at this dose as assessed by trypan blue viability assays. Western blot analyses were performed to determine if enhanced HO-1 gene expression after PDTC treatment correlated with increased HO-1 protein levels. An increase of HO-1 protein levels was evident at 2 h, peaking at 8 h and remaining elevated at 24 h after PDTC treatment of aVSM cells (Fig. 2) . The 
Induction of HO-1 mRNA expression by PDTC is dependent on both transcriptional and posttranscriptional mechanisms
To examine the mechanism(s) for increased expression of HO-1 in response to PDTC, we first examined whether HO-1 mRNA induction was dependent on gene transcription. Induction of HO-1 mRNA was completely abolished in the presence of actinomycin D (0.5 mg/ml), a potent inhibitor of RNA synthesis (Fig. 3) . In addition to increased HO-1 gene transcription, PDTC could also increase HO-1 gene expression by enhancing the stability of mRNA transcripts. We tested this possibility by determining whether PDTC affected the stability of HO-1 mRNA transcript. Cells were pretreated with PDTC for 4 h, washed, and subsequently exposed to actinomycin D either in the presence or absence of PDTC for 1, 2, 4, and 8 h. The decay of HO-1 transcripts in actinomycin D-treated cells was delayed in the presence of PDTC (Fig. 4) mg/ml ) prior to treatment with PDTC and then analyzed for HO-1 mRNA expression. Cycloheximide significantly attenuated the up-regulation of HO-1 mRNA steady-state levels in response to PDTC treatment, suggesting that new protein synthesis was also required for PDTC-induced HO-1 mRNA expression (Fig. 3) .
The 5 distal enhancer mediates PDTC-induced HO-1 gene transcription
To determine whether increased transcription of the HO-1 gene was mediated by its 5-upstream region, various fragments of the 11 kbp upstream region, including the promoter and distal enhancers, were linked to a CAT reporter gene and stably transfected in RAW 264.7 cells and assayed for CAT activity in response to PDTC. We used a cell line (RAW 264.7) for these studies involving transfections of HO-1 gene promoter and enhancers since primary cultures such as aVSM cells are difficult to transfect with high efficiency and reproducibility. Our laboratory has also extensively characterized the various stable transfectants (RAW 264.7 cells) used for these experiments (4, 20, 23) . By deletional analyses, we observed that the transcriptional activation of the HO-1 gene by PDTC is mediated not by the proximal promoter, but rather by the distal enhancer, AB1, located 10 kbp upstream of the transcription site (Fig. 5) . This distal enhancer regions contain putative DNA binding sites for transcriptional factor AP-1. By mutational analysis, we demonstrated that the AP-1 DNA binding elements were critical for PDTC-induced HO-1 gene transcription (Fig. 6) .
The transcription factor AP-1 is activated after exposure to PDTC Electrophoretic mobility shift assay were performed using a synthetic, double-stranded DNA probe specific for AP-1 to assess whether PDTC can increase AP-1 DNA binding activity in aVSM cells. Figure 7 shows activation of AP-1 DNA binding activity in nuclear lysates from PDTC-treated cells. Increased AP-1 binding activity was observed as early as 1 h and remained elevated at 4 h. The specificity of AP-1 binding activity was demonstrated by the ability of an unlabeled AP-1 oligonucleotide to compete with the radiolabeled AP-1 sequence for binding of nuclear factors (Fig. 7B ). An unlabeled Sp1 oligonucleotide containing an unrelated consensus sequence also did not compete with the radiolabeled AP-1 probe (Fig. 7B) .
DISCUSSION
HO, the rate-limiting enzyme in heme metabolism, plays a pivotal role in maintaining appropriate heme levels necessary for preserving cellular homeostasis. However, the inducible isoform, HO-1, is also up-regulated by a variety of non-heme inducers including heavy metals, cytokines, hormones, endotoxin, and heat shock (3) (4) (5) . Multiple byproducts are generated during heme degradation, each possessing unique functional characteristics that range from antioxidant (biliverdin, bilirubin) to signal transduction (carbon monoxide). Clearly, the chemical diversity of HO-1 inducers when taken in conjunction with the properties of the catalytic byproducts suggests HO may have a broader role(s) in both cellular and systemic functions. Indeed, emerging evidence supports the hypothesis of an extended role, as increased HO-1 gene expression has been shown to provide cellular protection against oxidative damage (8-10, 19, 20 ) as well as to modulate inflammation (21, 22) . Our laboratory has recently demonstrated that overexpression of HO-1 in human pulmonary epithelial cells resulted in cell growth arrest and increased resistance to hyperoxia (7) . It is becoming increasingly clear that the redox state of cells is important in modulating gene expression, and it has been suggested that reactive oxygen species may in part mediate the induction of HO-1 in response to various stimuli including hyperoxia, ultraviolet irradiation, and glutathione depletors (8, 19, 20, 23) . Therefore, when we recently demonstrated that NO-induced HO-1 expression occurred in a cGMP-independent manner (11), we hypothesized that reactive oxygen or nitrogen species may play a role in NO modulation of HO-1 gene expression. Surprisingly, the addition of PDTC, a powerful antioxidant and metal-chelating compound, did not attenuate the increase of HO-1 expression in response to NO, but up-regulated HO-1 gene expression in the absence of NO. (20) suggesting that modulation of gene transcription is the principal mechanism by which HO-1 is regulated. Our data further suggest that PDTC up-regulates HO-1 gene expression through activation of the transcription factor AP-1. AP-1 has been shown to behave as a redox-sensitive transcription factor that can be activated by either oxidant or antioxidant stimuli (24) . Our data support previous studies demonstrating that induction of AP-1 by antioxidant treatments requires de novo protein synthesis (25) , suggesting that PDTC is functioning as an antioxidant. However, it is also well established that the expression and /or DNA binding activity of c-Fos and c-Jun can be potently stimulated in many cell types by various pro-oxidants including heavy metals, hydrogen peroxide, and UV irradiation (26) . Note that even though PDTC is commonly regarded as an antioxidant, it can also bind and transport external copper ions into cells, raising the intracellular level of redox-active copper (27, 28) . Therefore, we cannot discount that an augmentation in the oxidant burden of the cell might be responsible for the activation of AP-1, culminating in increased HO-1 gene expression. Future experiments will be necessary to elucidate the underlying mechanism of AP-1 activation by PDTC.
In addition to activating AP-1, PDTC has also been shown to inhibit the transcription factor NF-kB (29, 30) , although the mechanism through which this occurs remains unclear. Some reports attribute this inhibition to the antioxidant properties of PDTC, and other investigators contend that inhibition does not involve redox modifications (31). We do not believe, however, that NF-kB plays an important role in PDTC-induced HO-1 gene transcription since there are no binding sites for NF-kB in the mouse HO-1 gene promoter or enhancers (16) (17) (18) 20) . However, our studies do not eliminate the possibility that transcription factors such as maf and Nrf families of proteins, transcription factor proteins that can bind to the consensus AP-1 binding sites (32) , are also involved in the activation of the HO-1 gene in response to PDTC.
We report here that PDTC is a potent inducer of HO-1 in aVSM cells through the activation of AP-1, albeit this is not the first report of PDTC inducing an endogenous antioxidant. Borello and Demple (14) reported 
